Loading organizations...
Based in Omaha, Nebraska, Bluestem Biosciences manufactures decarbonized commodity chemicals, such as 3-hydroxypropionic acid and acrylic acid, using the anaerobic fermentation of American corn. The company leverages engineered yeast strains and existing Midwest bioethanol infrastructure to replace traditional petrochemicals in plastics, nylon, acrylics, and various consumer products. This specific bioproduction process is designed to reduce carbon emissions by 75 percent or more when compared to conventional chemical manufacturing methods. Operating with a total team of 12 employees, the startup successfully raised $5 million in a pre-seed funding round to build its product discovery pipeline. This initial financing was led by Zero Infinity Partners with participation from Invest Nebraska and Matt Vining, while the company's advisory board includes industry veterans Jed Dean and Kristy Hawkins. Bluestem Biosciences was officially founded in January 2022 by Billy Hagstrom and Tyler Autera.
Bluestem Biosciences has raised $5.0M across 1 funding round.
Bluestem Biosciences has raised $5.0M in total across 1 funding round.
Bluestem Biosciences has raised $5.0M in total across 1 funding round.
Bluestem Biosciences's investors include Zero Infinity Partners.
Bluestem Biosciences has raised $5.0M across 1 funding round. Most recently, it raised $5.0M Seed in August 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 1, 2022 | $5M Seed | — | Zero Infinity Partners | Announced |
Bluestem Biosciences is a renewable chemicals company founded in 2022 and headquartered in Omaha, Nebraska, specializing in sustainable biomanufacturing of commodity chemicals like 3-hydroxypropionic acid (3-HP) using programmable biology and engineered yeast strains.[1][2][3] It serves the chemical industry by producing decarbonized platform chemicals from American corn via anaerobic fermentation, replacing petrochemicals for applications in materials, consumer products, plastics, acrylics, and nylon, while reducing carbon emissions by an estimated 75% or more.[1][2][3] The company leverages existing U.S. bioethanol infrastructure for cost-effective scaling, creating high-value opportunities for agriculture and domestic supply chains, and was named the Nebraska Business Development Center's 2023 Innovation Business of the Year.[2][3]
Bluestem's growth momentum includes filing 24 patent applications in February 2024 for its anaerobic chemical platform, targeting a combined total addressable market over $100 billion, and a business model that retrofits over 90% of existing ethanol facilities to minimize capital costs and accelerate commercialization.[2][3]
Bluestem Biosciences was founded in 2022 by CEO Billy Hagstrom, COO Tyler Autera, and CSO Jared Wenger, Ph.D., who brought expertise in leveraging digital biology for biomanufacturing.[2] The idea emerged from recognizing the Midwest's agricultural feedstocks—like corn—and underutilized bioethanol infrastructure as ideal for synthetic biology to produce bio-based chemicals, bypassing oil dependency.[2][3] Early traction came from developing a proprietary yeast strain for efficient fermentation of 3-HP, announced patent filings protecting a $100B+ market, and strategic location in Omaha to tap regional partnerships, workforce, and agriculture ties, with remote employees across states.[2]
A pivotal moment was earning the 2023 Innovation Business of the Year award from the Nebraska Business Development Center, highlighting its environmental and economic impact potential.[2]
Bluestem rides the bioeconomy and sustainable manufacturing trend, capitalizing on global decarbonization demands and U.S. pushes for supply chain resilience amid petrochemical vulnerabilities.[2][3] Timing aligns with rising bio-based chemical markets, agricultural innovation needs, and policies favoring domestic production, using abundant corn to counter oil price volatility and import reliance.[1][2][3] Market forces like ethanol infrastructure abundance (over 200 facilities) and partnerships in the Midwest amplify its edge, influencing the ecosystem by reinvesting in rural economies, expanding ag markets, and accelerating bio-chemical adoption for plastics and materials.[2][3]
Bluestem is poised for commercialization by retrofitting ethanol plants, potentially unlocking $100B+ markets with its patented platform amid surging demand for low-carbon chemicals.[2][3] Trends like synthetic biology advances, U.S. manufacturing resurgence, and ag-tech integration will propel growth, evolving its influence from Midwest innovator to national bioeconomy leader. This positions Bluestem to redefine chemical production, powering sustainable U.S. competitiveness from its agricultural roots.[3]
